Navigation Links
APCER Pharma Sponsors Major Industry Conference
Date:6/21/2012

Princeton, NJ (PRWEB) June 21, 2012

APCER Pharma Solutions, Inc., the truly global provider of strategic and operational services in safety reporting, medical affairs, and regulatory operations, announced today that it is sponsoring and exhibiting at the 48th Annual Meeting of the Drug Information Association (DIA). The meeting takes place at the Philadelphia Convention Center, June 24-28, 2012, and is expected to draw more than 7,000 professionals from the pharmaceutical, biotechnology, and medical device industries.

“We have been exhibiting at the DIA Annual Meeting since our founding, and it has provided an informal platform for our global safety experts to communicate with the industry professionals that bear the responsibility for regulatory compliance for their companies,” said Suneet Walia, President and CEO of APCER Pharma. “We are pleased to be able to support the meeting even further this year through sponsorship of the DIA Welcome Reception.”

DIA is a neutral, global, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Its Annual Meeting features more than 270 sessions presented by top experts across government, industry, academia, and patient groups, along with exhibitors from contract research organizations, technology providers, research centers, and academia. APCER Pharma will have representatives from its offices in North America, Europe, and Asia available at Booth #2736 to share information regarding developments in global safety regulations and client engagement models that drive quality and compliance.

About APCER Pharma Solutions
APCER Pharma is a global provider of strategic and operational services in safety reporting, medical affairs, and regulatory operations. Its international team of highly experienced healthcare professionals, scientists, and technologists provides pharmaceutical, biotechnology, medical device, and consumer product companies with deep knowledge of worldwide regulations and best practices to comply with them. For more information on APCER Pharma Solutions, please call (+1) 609-455-1600, or visit the company website at http://www.apcerpharma.com.

Read the full story at http://www.prweb.com/releases/pharmacovigilance/apcerpharma/prweb9626562.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ePharmaSolutions To Acquire Global Patient Recruitment Firm Polaris BioPharma
2. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
3. Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
4. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
5. aTyr Pharma Receives Industry Innovation Awards from TiE and San Diego Venture Group
6. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
7. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
8. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
9. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
10. Genesis Biopharma Mentioned Favorably in BioMedReports Article
11. Genesis Biopharma Issues Letter To Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research and Markets has announced the addition of the ... - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to ... ... to reach $15,737 million by 2022 from $6,521 in 2015, growing ... Omic technologies segment accounted for more than half of the ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi ... device open-access capability and technology platform, today announced ... leading biology focused preclinical drug discovery contract research ... will become a wholly-owned subsidiary of WuXi, and ... competences and providing greater services. The acquisition will ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, ... biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide ... email client designed to provide product vigilance departments with the flexibility and ease ...
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, ... on enhancing productivity in aquaculture and a majority-owned subsidiary ... that it has completed the listing of its common ... equity subscription from Intrexon. "AquaBounty,s listing on ... will broaden our exposure to the U.S. markets as ...
Breaking Biology Technology:
(Date:12/20/2016)... , Dec. 20, 2016 The rising ... rental and leasing is stoking significant interest in ... frequency technology, Bluetooth low energy (BLE), biometrics and ... the next wave of wireless technologies in the ... system to advanced access systems opens the market ...
(Date:12/16/2016)... , Dec 16, 2016 Research and Markets ... Market - Global Forecast to 2021" report to their offering. ... The biometric ... grow at a CAGR of 14.06% from 2016 to 2021. The ... is projected to reach 854.8 Million by 2021. The growth of ...
(Date:12/15/2016)... 15, 2016 ... Research and Markets has announced the addition of the ... The report forecasts the global military biometrics market to grow ... The report has been prepared based on an in-depth market analysis with ... growth prospects over the coming years. The report also includes a discussion ...
Breaking Biology News(10 mins):